Lime Chemicals

Which are the latest news on Lime Chemicals?

Why is Lime Chemicals Ltd falling/rising?

As of 05-Sep, the stock price of Lime Chemicals Ltd is at 14.95, unchanged from the previous session. The stock has shown positive performance with a 6.71% increase over the past week and a 10.25% gain year-to-date, despite underperforming its sector slightly today.

As of 05-Sep, the stock price of Lime Chemicals Ltd is currently at 14.95, showing no change from the previous trading session. Despite this stability in price, the stock has demonstrated a positive performance over various time frames. Over the past week, it has increased by 6.71%, while in the last month, it has risen by 7.32%. Year-to-date, the stock has gained 10.25%, contrasting with a decline of 10.21% in the Sensex during the same period. <BR><BR>Additionally, Lime Chemicals Ltd is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong upward trend in its price relative to these averages. Furthermore, there has been a notable increase in investor participation, with a delivery volume of 1.29 k on September 3, which is up by 22.18% compared to the 5-day average. This suggests growing interest and confidence among investors in the stock.<BR><BR>However, it is important to note that today, the stock has underperformed its sector by 0.27%. Despite this underperformance, the overall trends in recent weeks and months indicate a rising trajectory for Lime Chemicals Ltd, supported by increased trading activity and positive returns compared to the broader market.

Who are in the management team of Lime Chemicals?

The management team of Lime Chemicals includes A H Dawoodani (Managing Director), Shahnaz A Dawoodani and Akbar Virani (Directors), Husen Somji (Independent Director), Avinash Mukesh Jhaveri (Chairman & Independent Director), and S. Neha T. Botadra (Company Secretary & Compliance Officer).

The management team of Lime Chemicals includes the following individuals:<BR><BR>1. A H Dawoodani - Managing Director<BR>2. Shahnaz A Dawoodani - Director<BR>3. Akbar Virani - Director<BR>4. Husen Somji - Independent Director<BR>5. Avinash Mukesh Jhaveri - Chairman & Independent Director<BR>6. S. Neha T. Botadra - Company Secretary & Compliance Officer<BR><BR>If you have any more questions about the company or its operations, feel free to ask!

What does Lime Chemicals do?

Lime Chemicals Ltd manufactures Calcium Carbonate and operates in the Commodity Chemicals industry. Incorporated in 1970, it has a market cap of INR 9 Cr, with recent net sales of 6 Cr and a net profit of 0 Cr as of June 2026.

Overview: <BR>Lime Chemicals Ltd is engaged in the manufacture of Calcium Carbonate and operates within the Commodity Chemicals industry, classified as a Micro Cap company.<BR><BR>History: <BR>Lime Chemicals Ltd was incorporated in 1970 in Maharashtra. The company went public in 1986, marking a significant milestone. The latest quarterly results reported net sales and net profit for June 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 6 Cr (Quarterly Results - Jun 2026) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Jun 2026) <BR>Market-cap value: INR 9 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 2.47 <BR>Return on Equity: -1.12% <BR>Price-to-Book: 5.09<BR><BR>Contact Details: <BR>Address: 404/405 Neco Chambers 4 Th Flo, Plot No 48 Sector 11 Navi Mumbai Maharashtra : 400614 <BR>Tel: 91-022-27561976/77 <BR>Email: info@limechem.com <BR>Website: http://www.limechem.com

Who are the peers of the Lime Chemicals?

Lime Chemicals' peers include Emmessar Biotech, Kobo Biotech, Link Pharma Chem, Omkar Pharmachem, Sreechem Resins, Kuwer Industries, Bhagawati Oxygen, and Padmanabh Inds. Kobo Biotech leads in 1-year returns at 134.04%, while Lime Chemicals has a negative return of -16.37%.

Peers: The peers of Lime Chemicals are Emmessar Biotech, Kobo Biotech, Link Pharma Chem, Omkar Pharmachem, Sreechem Resins, Kuwer Industries, Bhagawati Oxygen, and Padmanabh Inds.<BR><BR>Quality Snapshot: Good management risk is observed at Sreechem Resins, while Average management risk is found at Emmessar Biotech, Link Pharma Chem, Kuwer Industries, Lime Chemicals, and Padmanabh Inds. The peers with Below Average management risk include Emmessar Biotech, Link Pharma Chem, Kuwer Industries, and the rest. Growth ratings show that Sreechem Resins has Below Average growth, while Padmanabh Inds has Average growth, and the rest have Below Average or do not qualify. In terms of Capital Structure, Sreechem Resins has Below Average, while Emmessar Biotech, Link Pharma Chem, Kuwer Industries, Lime Chemicals, and Padmanabh Inds also have Below Average ratings, and the rest do not qualify.<BR><BR>Return Snapshot: Kobo Biotech has the highest 1-year return at 134.04%, while Omkar Pharmachem has the lowest with N/A, and Lime Chemicals' 1-year return is -16.37%, indicating a negative performance compared to Kobo Biotech. Additionally, Sreechem Resins, Kuwer Industries, and Lime Chemicals have negative six-month returns.

How big is Lime Chemicals?

As of 31st August, Lime Chemicals Ltd has a market capitalization of 9.00 Cr and reported net sales of 11.50 Cr with a loss of 0.02 Cr over the latest four quarters. Shareholder's funds were 1.94 Cr and total assets were 10.10 Cr as of March 2025.

As of 31st August, Lime Chemicals Ltd has a market capitalization of 9.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Lime Chemicals reported net sales of 11.50 Cr. However, the company experienced a loss of 0.02 Cr during this period.<BR><BR>The latest annual period for the balance sheet is March 2025, where shareholder's funds amounted to 1.94 Cr and total assets were reported at 10.10 Cr.

Should I buy, sell or hold Lime Chemicals Ltd?

When is the next results date for Lime Chemicals Ltd?

The next results date for Lime Chemicals Ltd is 14 August 2026.

The next results date for Lime Chemicals Ltd is scheduled for 14 August 2026.

Are Lime Chemicals Ltd latest results good or bad?

Lime Chemicals Ltd's latest results show mixed performance, with a net profit of ₹0.03 crores and significant revenue growth, but ongoing challenges such as negative operating margins and a 20.39% decline in annual net sales raise concerns about its financial health. Investor sentiment is cautious, reflected in a "Strong Sell" rating due to working capital stress and negative equity.

Lime Chemicals Ltd's latest results present a mixed picture. On one hand, the company reported a net profit of ₹0.03 crores in Q4 FY26, which is an improvement from a loss of ₹0.08 crores in the previous quarter. Additionally, there was a significant revenue growth of 39.02% year-on-year, reaching ₹2.28 crores, and a robust 49.02% increase quarter-on-quarter.<BR><BR>However, despite these positive trends, the company continues to face serious challenges. The operating margin remains negative at -1.75%, indicating that core business operations are still loss-making. Furthermore, the annual performance shows a concerning decline in net sales of 20.39% for the nine-month period ending in FY26 compared to the same period in FY25.<BR><BR>Investor sentiment appears to be cautious, as reflected in the stock's recent decline and a "Strong Sell" rating. The company's financial health is also under scrutiny due to significant working capital stress, with current liabilities exceeding current assets, and a negative equity base.<BR><BR>In summary, while there are some signs of improvement, the overall financial situation remains precarious, and the company faces ongoing operational challenges that could hinder its recovery.

How has been the historical performance of Lime Chemicals?

Lime Chemicals has experienced a significant decline in net sales and profitability from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025, with negative operating profit margins and decreasing profit before and after tax. The company faces ongoing financial challenges, reflected in negative cash flow and reduced total assets and liabilities.

Answer:<BR>The historical performance of Lime Chemicals shows a declining trend in net sales and profitability over the years, with significant fluctuations in various financial metrics.<BR><BR>Breakdown:<BR>Lime Chemicals has experienced a steady decline in net sales from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The total operating income followed a similar trend, decreasing from INR 43.44 crore in March 2019 to INR 9.67 crore in March 2025. The raw material costs and purchase of finished goods have also varied, with raw material costs rising to INR 3.19 crore in March 2025 from INR 0.44 crore in March 2023. The company reported an operating profit margin that turned negative in recent years, reaching -1.34% in March 2025, compared to a positive margin of 7.87% in March 2019. Profit before tax showed a decline, with a profit of INR 0.24 crore in March 2025, down from INR 3.08 crore in March 2023. The profit after tax also reflected this downward trend, with INR 0.22 crore in March 2025 compared to INR 2.76 crore in March 2023. The company's total liabilities decreased from INR 24.07 crore in March 2020 to INR 10.10 crore in March 2025, while total assets also fell from INR 24.07 crore to INR 10.10 crore in the same period. Cash flow from operating activities has been negative in recent years, indicating ongoing financial challenges. Overall, Lime Chemicals has faced significant operational and financial difficulties, leading to a decline in key performance metrics over the years.

Who are the top shareholders of the Lime Chemicals?

The top shareholders of Lime Chemicals include Rahim Ahmed Dawoodani with 10.62%, Devanshi Parimal Merchant with 12.3%, and individual investors holding 64.14%. There is also a foreign institutional investor with 2.35% and five mutual fund schemes with a combined 0.05%, with no pledged promoter holdings.

The top shareholders of Lime Chemicals include both individual and institutional investors. The promoter with the highest holding is Rahim Ahmed Dawoodani, who owns 10.62% of the company. The highest public shareholder is Devanshi Parimal Merchant, holding 12.3%. Additionally, individual investors collectively hold a significant portion of 64.14%. There is also some institutional presence, with one foreign institutional investor (FII) holding 2.35% and five mutual fund schemes holding a combined 0.05%. Notably, there are no pledged promoter holdings.

Is Lime Chemicals overvalued or undervalued?

As of April 25, 2023, Lime Chemicals is considered overvalued and classified as "risky," with a PE ratio of 11.25, a Price to Book Value of 6.39, and a year-to-date return of -26.83%, significantly underperforming compared to its peers like Solar Industries and Godrej Industries.

As of 25 April 2023, Lime Chemicals has moved from a grade of "does not qualify" to "risky." The company is currently considered overvalued. Key ratios include a PE ratio of 11.25, a Price to Book Value of 6.39, and a PEG ratio of 0.08, which indicates a significant disparity in valuation metrics compared to its peers. <BR><BR>In comparison to its peers, Lime Chemicals' PE ratio is notably lower than Solar Industries, which has a PE of 123.77, and Godrej Industries, which stands at 46.63. The EV to EBITDA ratio of Lime Chemicals is -16.10, contrasting sharply with Godrej Industries' 34.36, highlighting its poor profitability relative to industry standards. Additionally, the company's recent stock performance has been underwhelming, with a year-to-date return of -26.83% compared to a 5.62% gain in the Sensex, reinforcing the notion of its overvaluation amidst a challenging market environment.

What is the technical trend for Lime Chemicals?

As of May 14, 2025, Lime Chemicals is in a mildly bearish trend, with daily moving averages and weekly Dow Theory indicating bearish sentiment, while mixed signals from MACD, Bollinger Bands, and KST suggest potential for stabilization.

As of 14 May 2025, the technical trend for Lime Chemicals has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by the daily moving averages indicating a bearish sentiment and the weekly Dow Theory also reflecting a mildly bearish outlook. The MACD shows a mildly bullish signal on the weekly chart but remains bearish on the monthly, which adds to the mixed signals. The Bollinger Bands and KST both indicate bearish conditions on the monthly, while the RSI shows no significant signals in either time frame. Overall, the strength of the bearish trend is moderate, with some conflicting indicators suggesting potential for stabilization.

Has Lime Chemicals declared dividend?

Lime Chemicals Ltd has declared a 12% dividend, amounting to 0.9700 per share, with an ex-date of September 25, 2006. However, the dividend yield is 0%, and total returns over various periods have shown significant losses.

Lime Chemicals Ltd has declared a 12% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 12%<BR>- Amount per share: 0.9700<BR>- Ex-date: 25 Sep 06<BR><BR>Dividend Yield: 0%<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was -33.64%, the dividend return was 0%, resulting in a total return of -33.64%.<BR><BR>For the 1-year period, the price return was -32.63%, the dividend return was 0%, leading to a total return of -32.63%.<BR><BR>Over the 2-year period, the price return was -23.64%, the dividend return was 0%, which resulted in a total return of -23.64%.<BR><BR>In the 3-year period, the price return was -34.55%, with a dividend return of 0%, culminating in a total return of -34.55%.<BR><BR>During the 4-year period, the price return was -42.15%, the dividend return was 0%, resulting in a total return of -42.15%.<BR><BR>For the 5-year period, the price return was -23.47%, the dividend return was 0%, leading to a total return of -23.47%.<BR><BR>Overall, while Lime Chemicals Ltd has declared a dividend, the dividend yield is 0%, indicating no returns from dividends in recent periods. The total returns across various periods reflect significant losses, suggesting a challenging financial performance.